The effect of weekly short message service communication on patient retention in care in the first year after HIV diagnosis: study protocol for a randomised controlled trial (WelTel Retain)

Introduction Interventions to improve retention in care after HIV diagnosis are necessary to optimise the timely initiation of antiretroviral therapy (ART) and HIV/AIDS control outcomes. Widespread mobile phone use presents new opportunities to engage patients in care. A randomised controlled trial (RCT), WelTel Kenya1, demonstrated that weekly text messages led to improved ART adherence and viral load suppression among those initiating ART. The aim of this study was to determine whether the WelTel intervention is an effective and cost-effective method of improving retention in care in the first year of care following HIV diagnosis. Methods and analysis WelTel Retain is an open, parallel group RCT that will be conducted at the Kibera Community Health Centre in Nairobi, Kenya. Over a 1-year period, we aim to recruit 686 individuals newly diagnosed with HIV who will be randomly allocated to an intervention or control arm (standard care) at a 1:1 ratio. Intervention arm participants will receive the weekly WelTel SMS ‘check-in’ to which they will be instructed to respond within 48 h. An HIV clinician will follow-up and triage any problems that are identified. Participants will be followed for 1 year, with a primary endpoint of retention in care at 12 months. Secondary outcomes include retention in stage 1 HIV care (patients return to the clinic to receive their first CD4 results) and timely ART initiation. Cost-effectiveness will be analysed through decision-analytic modelling. Ethics and dissemination Ethical approval has been obtained from the University of British Columbia and the African Medical and Research Foundation. This trial will test the effectiveness and cost-effectiveness of the WelTel intervention to engage patients during the first year of HIV care. Trial results and economic evaluation will help inform policy and practice on the use of WelTel in the early stages of HIV care. Trial registration ClinicalTrials.gov NCT01630304.

[1]  Dan Myung,et al.  Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. , 2011, AIDS patient care and STDs.

[2]  Caroline O. Buckee,et al.  Heterogeneous Mobile Phone Ownership and Usage Patterns in Kenya , 2012, PloS one.

[3]  A. Rothberg.  Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2008 .

[4]  Lehana Thabane,et al.  In-Depth Analysis of Patient-Clinician Cell Phone Communication during the WelTel Kenya1 Antiretroviral Adherence Trial , 2012, PloS one.

[5]  S. Rosen,et al.  Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review , 2011, PLoS medicine.

[6]  Donald Hedeker,et al.  Analysis of binary outcomes with missing data: missing = smoking, last observation carried forward, and a little multiple imputation. , 2007, Addiction.

[7]  N. Ford,et al.  Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in Lesotho , 2010, AIDS.

[8]  J. Haybittle,et al.  Repeated assessment of results in clinical trials of cancer treatment. , 1971, The British journal of radiology.

[9]  R. Kaplan,et al.  Time-driven activity-based costing. , 2003, Harvard business review.

[10]  G. Maartens,et al.  Factors Influencing Retention in Care after Starting Antiretroviral Therapy in a Rural South African Programme , 2011, PloS one.

[11]  Deborah K. Padgett,et al.  Qualitative and Mixed Methods in Public Health , 2011 .

[12]  G. John-Stewart,et al.  Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in Kenya , 2011, AIDS.

[13]  C. Yiannoutsos,et al.  Retention in Care among HIV-Infected Patients in Resource-Limited Settings: Emerging Insights and New Directions , 2010, Current HIV/AIDS reports.

[14]  C. Yiannoutsos,et al.  Retention in Care and Connection to Care among HIV-Infected Patients on Antiretroviral Therapy in Africa: Estimation via a Sampling-Based Approach , 2011, PloS one.

[15]  C. Sherbourne,et al.  The MOS social support survey. , 1991, Social science & medicine.

[16]  A. Greene,et al.  Patients’ Engagement With “Sweet Talk” – A Text Messaging Support System for Young People With Diabetes , 2008, Journal of medical Internet research.

[17]  David Huh,et al.  Peer Support and Pager Messaging to Promote Antiretroviral Modifying Therapy in Seattle: A Randomized Controlled Trial , 2009, Journal of acquired immune deficiency syndromes.

[18]  W. Jack,et al.  Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial , 2010, The Lancet.

[19]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[20]  K. Laserson,et al.  Home-Based HIV Testing and Counseling in Rural and Urban Kenyan Communities , 2013, Journal of acquired immune deficiency syndromes.

[21]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[22]  Rob Baltussen,et al.  Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2003 .

[23]  M. Fox,et al.  Defining retention and attrition in pre‐antiretroviral HIV care: proposals based on experience in Africa , 2012, Tropical medicine & international health : TM & IH.